Clinical pathway for the management of uninvestigated Dyspepsia among adults in family and community practice: Updated 2021
- Author:
Nenacia Ranali Nirena P. Mendoza
;
Noel M. Espallardo
;
Anna Guia O. Limpoco
;
Jane Efflyn Lardizabal-Bunyi
;
Abigael C. Andal-Saniano
;
Ma. Elinore Alba-Concha
;
Ma. Teresa Tricia G. Bautista
;
Rhodora F. Pesebre
- Publication Type:Other Types
- MeSH:
Dyspepsia;
Community Health Services;
Critical Pathways
- From:
The Filipino Family Physician
2021;59(2):182-197
- CountryPhilippines
- Language:English
-
Abstract:
Background:Uninvestigated dyspepsia is a common complaint in family practice in the Philippines. Patients usually seek consult due to severity of symptoms which affect their quality of life. The goals of management are short- and long-term symptom control, with reversal of possible underlying mechanisms, achievable through a combination of pharmacologic and non-pharmacologic interventions.
Objective:The main objective of this pathway is to guide family physicians and primary care physicians in the assessment, diagnosis and management of adult patients with uninvestigated dyspepsia through a shared decision-making process.
Method:This clinical pathway is an update of the PAFP’s Clinical Pathways for the Management of Dyspepsia in Adults (2016). The current panel utilized the ADAPTE method and prioritized reviewing relevant clinical practice guidelines from 2017 to present. Grading of recommendation was achieved through a mixture of strength of available evidence and a consensus from a panel of experts.
Summary of Recommendations:The main changes in the recommendations in this update are as follows: symptom-based classification of dyspepsia, screening for anxiety and depression, family and SCREEM assessment; initiation of therapeutic trial for most patients to whom H. pylori testing is not available; extension of initial PPI treatment to 4-8 weeks, consideration of antacids/alginates for immediate symptom relief, consideration of tricyclic antidepressants for non-responders to initial treatment; symptom-based non-pharmacologic advice, consideration of counseling and other psychosocial interventions; empowerment for self-treatment and as-needed therapy for those who have completed the initial treatment regimen
Dissemination and Implementation:This guideline shall be disseminated and implemented at the clinic and organizational level. It will be published in the “The Filipino Family Physician” journal, social media platforms and will be disseminated through PAFP local chapters, training institutions and during the national convention. Non-FCM primary care physicians will also be reached through relevant agencies. It shall be included in the references required during training activities and national exams of accredited training institutions, in coordination with the PAFP committee on Residency Training. It shall be incorporated in checklists for compliance in audits and QA cycles, with support from the PAFP committee on Quality Assurance and that on Standards for Family Practice. Feedback on utility and applicability will be actively sought from the intended users and other stakeholders.
- Full text:PAFP-Journal_July_December-59-2-2021-pages-59-74.pdf
